2181 Metformin Hydrchloride 500mg (Sustained-release) and Glimipride 3mg Tablet IP
Dual Action Diabetes Control with Extended Release
₹30.00
This formulation combines Metformin Hydrochloride 500mg (Sustained-Release) and Glimipride 3mg, offering a synergistic approach for managing type 2 diabetes. The sustained-release metformin ensures steady, long-lasting glucose regulation, while Glimipride enhances insulin secretion for optimal efficacy.